Australian Researchers Develop Nanomaterial That Could Regrow Jawbone, Preclinical Study Shows

Australian researchers have developed a biodegradable calcium-aluminosilicate nanomaterial that could eventually allow children born with cleft lip and palate to regrow missing jawbone without invasive surgery, according to studies published in ACS Nano and reported by Eurekalert.

During preclinical evaluations, tests on the novel nanomaterial revealed it generated roughly 80 percent greater new bone volume compared to a control material following an eight-week period.

Cleft lip and palate affects approximately one in 700 children, developing when parts of the upper lip or roof of the mouth fail to fuse completely during pregnancy. Correcting the resulting jawbone defects represents a major clinical challenge that can impact eating, breathing, speech, and social development.

“One of the biggest challenges for children born with cleft lip and palate is repairing the bone defect in the jaw.”

commented lead investigator Associate Professor Chun Xu, a Sydney Horizon Fellow within the Faculty of Medicine and Health at the University of Sydney.

“While some children with minor defects are treated as infants, many patients need to wait until they are around 10 to 12 years old before surgeons can take bone from another part of the body and graft it into the defect.” Associate Professor Xu

Associate Professor Xu also stated: “That means many kids live with difficulties for years. It can affect their breathing, eating and speech. Most heartbreaking of all, it can have a huge impact on their confidence and social development.”

More than four million bone repair procedures occur worldwide each year. Traditional treatments often depend on bone harvested from patients or animal-derived materials that primarily offer structural support. The new approach instead uses a biodegradable nanomaterial developed at the University of Sydney in collaboration with the University of Queensland, drawing on work from the University of Sydney School of Dentistry, Charles Perkins Centre, and Sydney Nano.

Rather than supplying external growth factors, the material activates a naturally occurring growth factor called latent Transforming Growth Factor β1 (TGF-β1) at approximately 10 times the level achieved using conventional methods. The protein recruits stem cells to the damaged area and encourages them to develop into bone-producing cells.

As new tissue forms, the biodegradable material is gradually replaced by the patient’s own bone. The material also promoted blood clotting within about 30 seconds to help stabilize the injury during early healing.

Associate Professor Xu stated:

“The material activates dormant repair signals in the body, triggering a cascade of healing processes that attract bone-forming stem cells and stimulate new bone growth,” and added: “Our body already contains many of the signals needed for tissue repair. We’ve developed a material that can help activate those signals at the right place and time. Instead of supplying external growth factors, we’re encouraging the body to use its own healing potential.”

The University of Sydney, founded in 1850, is Australia’s oldest university and one of the first public, secular institutions in the British Empire to admit students solely on academic merit and welcome women on equal terms. It was established via the University of Sydney Act 1850 (NSW) and inaugurated in 1852, later receiving a royal charter from Queen Victoria in 1858.

This study represents the initial instance in which a unified nanomaterial platform has successfully integrated fast blood coagulation, the stimulation of native growth factors, the attraction of stem cells capable of forming bone, and accelerated bone healing.

While the technology offers a potential future alternative to procedures that have changed little in more than 50 years, the technology remains in the preclinical stage, and further testing is required before human trials can begin.